Telehealth Abortion Access Upheld Amid FDA Safety Review
A federal judge's ruling keeps telehealth abortion available for now, as the FDA reviews mifepristone's safety. Louisiana's case seeking a telemedicine ban will proceed after the review.
Telehealth abortion services will remain accessible for the time being, following a federal judge's ruling that keeps the abortion pill mifepristone available while the FDA conducts a safety review. The ruling comes as Louisiana sought to ban the use of mifepristone through telemedicine.
The judge's decision means that individuals seeking medication abortion can continue to access the procedure remotely, at least until the FDA completes its examination of mifepristone's safety profile. This provides a temporary reprieve for those relying on telehealth abortion options, particularly in states with restrictive abortion laws.
The case in question was brought by Louisiana, which sought to prohibit the use of mifepristone through telemedicine. The state argued that the FDA's original approval of the drug was flawed and that its use in remote abortion services poses safety risks.
Source: NPR
